Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial by Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study by Goss, Glenwood, Dr Prof, Tsai, Chun-Ming, Prof, Shepherd, Frances A, Prof, Bazhenova, Lyudmila, Prof, Lee, Jong Seok, MD, Chang, Gee-Chen, MD, Crino, Lucio, MD, Satouchi, Miyako, MD, Chu, Quincy, MD, Hida, Toyoaki, MD, Han, Ji-Youn, Prof, Juan, Oscar, MD, Dunphy, Frank, Prof, Nishio, Makoto, MD, Kang, Jin-Hyoung, MD, Majem, Margarita, MD, Mann, Helen, MSc, Cantarini, Mireille, MD, Ghiorghiu, Serban, MD, Mitsudomi, Tetsuya, Prof

Get full text

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, rand... by Seto, Takashi, MD, Kato, Terufumi, MD, Nishio, Makoto, MD, Goto, Koichi, MD, Atagi, Shinji, MD, Hosomi, Yukio, MD, Yamamoto, Noboru, MD, Hida, Toyoaki, MD, Maemondo, Makoto, MD, Nakagawa, Kazuhiko, Prof, Nagase, Seisuke, MD, Okamoto, Isamu, MD, Yamanaka, Takeharu, PhD, Tajima, Kosei, MSc, Harada, Ryosuke, BS, Fukuoka, Masahiro, MD, Yamamoto, Nobuyuki, Prof

Get full text

CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study by Seto, Takashi, MD, Kiura, Katsuyuki, Prof, Nishio, Makoto, MD, Nakagawa, Kazuhiko, Prof, Maemondo, Makoto, MD, Inoue, Akira, MD, Hida, Toyoaki, MD, Yamamoto, Nobuyuki, MD, Yoshioka, Hiroshige, MD, Harada, Masao, MD, Ohe, Yuichiro, MD, Nogami, Naoyuki, MD, Takeuchi, Kengo, MD, Shimada, Tadashi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG060... by Goto, Koichi, Dr, Ohe, Yuichiro, MD, Shibata, Taro, MSc, Seto, Takashi, MD, Takahashi, Toshiaki, MD, Nakagawa, Kazuhiko, Prof, Tanaka, Hiroshi, MD, Takeda, Koji, MD, Nishio, Makoto, MD, Mori, Kiyoshi, MD, Satouchi, Miyako, MD, Hida, Toyoaki, MD, Yoshimura, Naruo, MD, Kozuki, Toshiyuki, MD, Imamura, Fumio, MD, Kiura, Katsuyuki, Prof, Okamoto, Hiroaki, MD, Sawa, Toshiyuki, MD, Tamura, Tomohide, MD

Get full text

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyper... by Kubota, Kaoru, Prof, Hida, Toyoaki, MD, Ishikura, Satoshi, MD, Mizusawa, Junki, MSc, Nishio, Makoto, MD, Kawahara, Masaaki, MD, Yokoyama, Akira, MD, Imamura, Fumio, MD, Takeda, Koji, MD, Negoro, Shunichi, MD, Harada, Masao, MD, Okamoto, Hiroaki, MD, Yamamoto, Nobuyuki, MD, Shinkai, Tetsu, MD, Sakai, Hiroshi, MD, Matsui, Kaoru, MD, Nakagawa, Kazuhiko, Prof, Shibata, Taro, MSc, Saijo, Nagahiro, Prof, Tamura, Tomohide, MD

Get full text

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study by Fujimoto, Nobukazu, Okada, Morihito, Kijima, Takashi, Aoe, Keisuke, Kato, Terufumi, Nakagawa, Kazuhiko, Takeda, Yuichiro, Hida, Toyoaki, Kanai, Kuninobu, Hirano, Jun, Ohe, Yuichiro

Get full text

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma by Nakagawa, Kazuhiko, Kijima, Takashi, Okada, Morihito, Morise, Masahiro, Kato, Motoyasu, Hirano, Katsuya, Fujimoto, Nobukazu, Takenoyama, Mitsuhiro, Yokouchi, Hiroshi, Ohe, Yuichiro, Hida, Toyoaki, Aoe, Keisuke, Kishimoto, Takumi, Hirokawa, Masato, Matsuki, Hironori, Kaneko, Yutaro, Yamada, Taketo, Morimoto, Chikao, Takeda, Masayuki

Get full text

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial by Rittmeyer, Achim, MD, Barlesi, Fabrice, PhD, Waterkamp, Daniel, MD, Park, Keunchil, MD, Ciardiello, Fortunato, MD, von Pawel, Joachim, MD, Gadgeel, Shirish M, MD, Hida, Toyoaki, PhD, Kowalski, Dariusz M, PhD, Dols, Manuel Cobo, MD, Cortinovis, Diego L, PhD, Leach, Joseph, MD, Polikoff, Jonathan, MD, Barrios, Carlos, MD, Kabbinavar, Fairooz, MD, Frontera, Osvaldo Arén, MD, De Marinis, Filippo, MD, Turna, Hande, MD, Lee, Jong-Seok, MD, Ballinger, Marcus, PhD, Kowanetz, Marcin, PhD, He, Pei, PhD, Chen, Daniel S, MD, Sandler, Alan, MD, Gandara, David R, Dr

Get full text

Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial by Solomon, Benjamin J., Dagogo-Jack, Ibiayi, Lee, Se-Hoon, Boyer, Michael J., Ramalingam, Suresh S., Carcereny, Enric, Felip, Enriqueta, Han, Ji-Youn, Hida, Toyoaki, Hughes, Brett G.M., Kim, Sang-We, Nishio, Makoto, Seto, Takashi, Okamoto, Tatsuro, Zhang, Xiaoxi, Martini, Jean-Francois, Wang, Erjian, De Beukelaer, Steven, Bauer, Todd M.

Get full text

Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations by Ninomiya, Kiichiro, Teraoka, Shunsuke, Zenke, Yoshitaka, Kenmotsu, Hirotsugu, Nakamura, Yukiko, Okuma, Yusuke, Tamiya, Akihiro, Nosaki, Kaname, Morise, Masahiro, Aokage, Keiju, Oya, Yuko, Kozuki, Toshiyuki, Sakamoto, Tomohiro, Tanaka, Kentaro, Tanaka, Hisashi, Tanizaki, Junko, Miura, Satoru, Mizutani, Hideaki, Miyauchi, Eisaku, Yamaguchi, Ou, Ebi, Noriyuki, Goto, Yasushi, Sasaki, Takaaki, Daga, Haruko, Morita, Satoshi, Yamanaka, Takeharu, Amano, Shinsuke, Hasegawa, Kazuo, Imamura, Chiyo K., Suzuki, Kenichi, Nakajima, Kazuko, Nishimoto, Hitomi, Oizumi, Satoshi, Hida, Toyoaki, Hotta, Katsuyuki, Takiguchi, Yuichi

Get full text